NextGen Healthcare Information Systems, LLC, a fully-owned subsidiary of Quality Systems, Inc. (QSII - Free Report) , recently declared its receipt of the ONC HIT certification for its latest offering. This positive piece of news should leverage investor confidence in the stock. On a year-to-date basis, the company’s share price surged 31%.
On Sep 18, NextGen Inpatient Clinicals version 2.6 was certified as a Complete Electronic Health Record (Complete EHR) by the Certification Commission for Health Information Technology (CCHIT), an ONC Authorized Certification Body (ONC-ACB). The device is now compliant with the ONC 2014 Edition criteria, which supports both Stage 1 and 2 Meaningful Use (MU) measures.
The EHR technology certification is an important milestone for QSII, which renders a competitive edge to the company’s product portfolio. Compliance with MU Stage 2 was an essential benchmark that was required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
The NextGen Inpatient Clinicals is a proven solution at critical access and community hospitals in the U.S. This comprehensive clinical system includes computer physician order entry (CPOE), clinical decision support, order management, advanced reporting, clinical data repository and additional features.
Earlier, in Sep, the NextGen Healthcare Information Systems subsidiary hit the headlines by presenting a clinical decision support (CDS) tool that will help healthcare providers achieve evidence-based clinical knowledge much more easily. NextGen’s client Willamette Valley Providers (WVP) has agreed to take the program live with a commercial EHR.
Quality Systems presently has a Zacks Rank #3 (Hold). While we remain on the sidelines regarding QSII, other medical stocks that are worth considering include Cardinal Health, Inc. (CAH - Free Report) , Bio-Rad Laboratories, Inc. (BIO - Free Report) and STRAUMANN HLD N AKT (SAUHF - Free Report) . All these stocks carry a Zacks Rank #1 (Strong Buy).